McKesson (MCK)

NYSE Health Care Health Care Distributors S&P 500

$1,060.84

-11.16 (-1.04%)

Close of Nov 06, 2026 · end-of-day data

Source: McKesson's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$198.53B	$208.36B	$214.32B	$231.05B	$238.23B	$263.97B	$276.71B	$308.95B	$359.05B	$403.43B
Cost of revenue	$187.26B	$197.17B	$202.56B	$219.03B	$226.08B	$250.84B	$264.35B	$296.12B	$345.73B	$388.88B
Gross profit	$11.27B	$11.18B	$11.75B	$12.02B	$12.15B	$13.13B	$12.36B	$12.83B	$13.32B	$14.55B
Research & development	$341.00M	$125.00M	$71.00M	$96.00M	—	—	—	—	—	—
Selling, general & admin	$7.45B	$8.14B	$8.44B	$9.18B	$8.85B	$10.54B	$7.78B	$8.66B	$8.51B	$8.10B
Operating income	$7.12B	$762.00M	$886.00M	$2.49B	-$5.04B	$2.04B	$4.38B	$3.91B	$4.42B	$6.21B
Interest expense	—	$283.00M	$264.00M	$249.00M	$217.00M	$178.00M	$248.00M	$252.00M	$265.00M	$247.00M
Pre-tax income	$6.89B	$239.00M	$610.00M	$1.14B	-$5.03B	$1.93B	$4.63B	$3.79B	$4.36B	$6.20B
Income tax	$1.61B	-$53.00M	$356.00M	$18.00M	-$695.00M	$636.00M	$905.00M	$629.00M	$878.00M	$1.10B
Net income	$5.07B	$67.00M	$34.00M	$900.00M	-$4.54B	$1.11B	$3.56B	$3.00B	$3.29B	$4.76B
EBITDA	$8.03B	$1.71B	$1.20B	$2.82B	-$4.70B	$2.35B	$4.65B	$4.19B	$4.69B	$6.50B
EPS (basic)	$22.95	$0.32	$0.17	$4.98	$-28.26	$7.32	$25.23	$22.54	$25.86	$38.55
EPS (diluted)	$22.73	$0.32	$0.17	$4.95	$-28.26	$7.23	$25.03	$22.39	$25.72	$38.38
Diluted shares	223.00M	209.00M	197.30M	181.60M	160.60M	154.10M	142.20M	134.10M	128.10M	124.10M
Gross margin	5.7%	5.4%	5.5%	5.2%	5.1%	5.0%	4.5%	4.2%	3.7%	3.6%
Operating margin	3.6%	0.4%	0.4%	1.1%	-2.1%	0.8%	1.6%	1.3%	1.2%	1.5%
Net margin	2.6%	0.0%	0.0%	0.4%	-1.9%	0.4%	1.3%	1.0%	0.9%	1.2%

Balance sheet

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash & equivalents	$2.78B	$2.67B	$2.98B	$4.01B	$6.28B	$3.53B	$4.68B	$4.58B	$5.69B	$3.98B
Receivables	$18.21B	$17.71B	$18.25B	$19.95B	$19.18B	$18.58B	$19.41B	$21.62B	$25.64B	$27.98B
Inventory	$15.28B	$16.31B	$16.71B	$16.73B	$19.25B	$18.70B	$19.69B	$21.14B	$23.00B	$24.21B
Total current assets	$36.95B	$37.14B	$38.47B	$42.22B	$45.38B	$46.23B	$44.29B	$47.97B	$55.40B	$57.21B
Goodwill	$10.59B	$10.92B	$9.36B	$9.36B	$9.49B	$9.45B	$9.95B	$10.13B	$10.02B	$11.32B
Total assets	$60.97B	$60.38B	$59.67B	$61.25B	$65.02B	$63.30B	$62.32B	$67.44B	$75.14B	$82.32B
Total current liabilities	$35.61B	$36.69B	$37.63B	$42.62B	$44.10B	$48.47B	$47.96B	$52.36B	$61.60B	$67.02B
Short-term debt	$1.06B	$1.13B	$330.00M	$1.05B	$0	$0	$0	$0	$1.19B	$1.27B
Long-term debt	$7.30B	$6.75B	$7.26B	$6.33B	$6.41B	$5.88B	$5.59B	$5.63B	$5.65B	$6.53B
Total debt	$8.36B	$7.88B	$7.59B	$7.39B	$6.41B	$5.88B	$5.59B	$5.63B	$6.84B	$7.79B
Total liabilities	$49.87B	$50.58B	$51.58B	$56.16B	$65.04B	$65.57B	$64.18B	$69.41B	$77.21B	$84.50B
Shareholders' equity	$11.10B	$9.80B	$8.09B	$5.09B	-$21.00M	-$2.27B	-$1.86B	-$1.97B	-$2.07B	-$2.17B

Cash flow

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Operating cash flow	$4.74B	$4.34B	$4.04B	$4.37B	$4.54B	$4.43B	$5.16B	$4.31B	$6.08B	$6.16B
Capital expenditures	$404.00M	$405.00M	$426.00M	$362.00M	$451.00M	$388.00M	$390.00M	$431.00M	$537.00M	$436.00M
Free cash flow	$4.34B	$3.94B	$3.61B	$4.01B	$4.09B	$4.05B	$4.77B	$3.88B	$5.55B	$5.72B
Investing cash flow	-$3.27B	-$2.99B	-$1.38B	-$579.00M	-$415.00M	-$89.00M	-$542.00M	-$1.07B	-$733.00M	-$3.43B
Financing cash flow	-$2.07B	-$3.08B	-$2.23B	-$2.73B	-$1.69B	-$6.32B	-$4.37B	-$3.34B	-$3.96B	-$4.63B
Dividends paid	$253.00M	$262.00M	$292.00M	$294.00M	$276.00M	$277.00M	$292.00M	$314.00M	$345.00M	$381.00M
Share buybacks	$2.31B	$1.71B	$1.64B	$1.93B	$742.00M	$3.52B	$3.64B	$3.02B	$3.15B	$4.75B
Stock-based compensation	$115.00M	$69.00M	$95.00M	$119.00M	$151.00M	$161.00M	$162.00M	$182.00M	$226.00M	$247.00M
Depreciation & amortization	$910.00M	$951.00M	$317.00M	$335.00M	$344.00M	$312.00M	$272.00M	$279.00M	$272.00M	$287.00M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$80.90B	$76.36B	$79.28B	$93.65B	$95.29B	$90.82B	$97.83B	$103.15B	$106.16B	$96.30B	$105.38B	$110.96B
Cost of revenue	$77.75B	$72.77B	$76.13B	$90.40B	$92.01B	$87.18B	$94.55B	$99.61B	$102.47B	$92.25B	$101.69B	$107.00B
Gross profit	$3.15B	$3.58B	$3.15B	$3.25B	$3.28B	$3.64B	$3.28B	$3.54B	$3.69B	$4.04B	$3.69B	$3.96B
Selling, general & admin	$2.51B	$2.19B	$2.00B	$2.50B	$2.03B	$1.98B	$2.20B	$2.07B	$2.03B	$1.80B	$2.26B	$2.27B
Operating income	$642.00M	$1.22B	$1.03B	$578.00M	$1.22B	$1.59B	$1.04B	$1.41B	$1.62B	$2.15B	$1.32B	$1.60B
Interest expense	$64.00M	$80.00M	$75.00M	$78.00M	$67.00M	$45.00M	$49.00M	$74.00M	$63.00M	$61.00M	$77.00M	$105.00M
Pre-tax income	$612.00M	$1.17B	$1.08B	$534.00M	$1.23B	$1.51B	$1.05B	$1.40B	$1.63B	$2.12B	$1.31B	$1.56B
Income tax	-$18.00M	$340.00M	$124.00M	$247.00M	$298.00M	$209.00M	$220.00M	$232.00M	$380.00M	$270.00M	$276.00M	$266.00M
Net income	$589.00M	$791.00M	$915.00M	$241.00M	$879.00M	$1.26B	$784.00M	$1.11B	$1.19B	$1.68B	$614.00M	$1.22B
EBITDA	$704.00M	$1.28B	$1.20B	$741.00M	$1.38B	$1.74B	$1.19B	$1.59B	$1.81B	$2.35B	$1.51B	$1.80B
EPS (basic)	$4.45	$6.05	$7.04	$1.88	$6.98	$9.98	$6.28	$8.95	$9.63	$13.72	$5.17	$10.47
EPS (diluted)	$4.42	$6.00	$7.00	$1.87	$6.95	$9.92	$6.25	$8.92	$9.59	$13.65	$5.15	$10.44
Diluted shares	133.30M	-800.00K	130.70M	129.30M	126.60M	-700.00K	125.50M	124.40M	123.70M	-400.00K	119.20M	116.70M
Gross margin	3.9%	4.7%	4.0%	3.5%	3.4%	4.0%	3.4%	3.4%	3.5%	4.2%	3.5%	3.6%
Operating margin	0.8%	1.6%	1.3%	0.6%	1.3%	1.8%	1.1%	1.4%	1.5%	2.2%	1.3%	1.4%
Net margin	0.7%	1.0%	1.2%	0.3%	0.9%	1.4%	0.8%	1.1%	1.1%	1.7%	0.6%	1.1%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$1.98B	$4.58B	$2.30B	$2.51B	$1.13B	$5.69B	$2.42B	$4.00B	$2.96B	$3.98B	$5.16B	$6.53B
Receivables	$23.07B	$21.62B	$23.74B	$25.27B	$25.83B	$25.64B	$28.16B	$28.29B	$28.21B	$27.98B	$30.32B	$30.81B
Inventory	$22.02B	$21.14B	$25.57B	$24.18B	$23.84B	$23.00B	$25.07B	$26.13B	$27.07B	$24.21B	$26.26B	$28.22B
Total current assets	$47.64B	$47.97B	$52.25B	$53.34B	$51.74B	$55.40B	$56.80B	$59.89B	$59.70B	$57.21B	$62.84B	$66.69B
Goodwill	$9.97B	$10.13B	$10.12B	$10.09B	$10.00B	$10.02B	$11.37B	$11.28B	$11.32B	$11.32B	$11.28B	$11.27B
Total assets	$66.51B	$67.44B	$71.67B	$72.43B	$71.08B	$75.14B	$81.31B	$84.16B	$84.19B	$82.32B	$88.33B	$92.32B
Total current liabilities	$51.66B	$52.36B	$56.43B	$58.77B	$58.56B	$61.60B	$64.33B	$68.03B	$68.13B	$67.02B	$70.36B	$74.40B
Short-term debt	$218.00M	$0	$51.00M	$53.00M	$2.42B	$1.19B	$1.25B	$1.75B	$1.13B	$1.27B	$1.30B	$794.00M
Long-term debt	$5.67B	$5.63B	$5.63B	$5.74B	$5.59B	$5.65B	$7.78B	$7.76B	$6.56B	$6.53B	$9.73B	$9.21B
Total debt	$5.89B	$5.63B	$5.69B	$5.80B	$8.01B	$6.84B	$9.03B	$9.51B	$7.69B	$7.79B	$11.03B	$10.00B
Total liabilities	$68.56B	$69.41B	$73.42B	$75.45B	$74.17B	$77.21B	$83.28B	$85.90B	$85.49B	$84.50B	$92.57B	$96.28B
Shareholders' equity	-$2.05B	-$1.97B	-$1.75B	-$3.02B	-$3.08B	-$2.07B	-$1.97B	-$1.74B	-$1.30B	-$2.17B	-$4.24B	-$3.95B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$254.00M	$4.15B	-$1.38B	$2.10B	-$2.38B	$7.75B	-$918.00M	$2.42B	$1.23B	$3.42B	-$220.00M	$3.07B
Capital expenditures	$90.00M	$188.00M	$106.00M	$136.00M	$126.00M	$169.00M	$111.00M	$106.00M	$108.00M	$111.00M	$112.00M	$65.00M
Free cash flow	$164.00M	$3.96B	-$1.49B	$1.96B	-$2.51B	$7.58B	-$1.03B	$2.31B	$1.12B	$3.31B	-$332.00M	$3.00B
Investing cash flow	-$180.00M	-$577.00M	-$87.00M	-$286.00M	-$136.00M	-$224.00M	-$3.56B	-$24.00M	-$269.00M	$425.00M	-$214.00M	-$130.00M
Financing cash flow	-$622.00M	-$968.00M	-$809.00M	-$1.60B	$1.30B	-$2.85B	$1.18B	-$961.00M	-$2.03B	-$2.82B	$1.63B	-$1.57B
Dividends paid	$83.00M	$82.00M	$82.00M	$80.00M	$92.00M	$91.00M	$90.00M	$89.00M	$101.00M	$101.00M	$102.00M	$96.00M
Share buybacks	$842.00M	$678.00M	$527.00M	$1.49B	$827.00M	$300.00M	$581.00M	$818.00M	$680.00M	$2.67B	$2.53B	$894.00M
Depreciation & amortization	$62.00M	$62.00M	$169.00M	$163.00M	$153.00M	$151.00M	$157.00M	$188.00M	$188.00M	$196.00M	$195.00M	$197.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.